GOSS (Gossamer Bio) Common Stock: $0.05 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GOSS Gossamer Bio Inc GOSS
19 GF Score
Price $0.14
! 4 Warning Signs
View Full Analysis

What is Gossamer Bio Common Stock?

Gossamer Bio GOSS -9.21% 19 Common Stock is $0.05 Mil as of Jun. 2026. GuruFocus rates GOSS with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

Gossamer Bio's quarterly common stock stayed the same from Dec. 2025 ($0.02 Mil) to Mar. 2026 ($0.02 Mil) but then increased from Mar. 2026 ($0.02 Mil) to Jun. 2026 ($0.05 Mil).

Gossamer Bio's annual common stock stayed the same from Dec. 2023 ($0.02 Mil) to Dec. 2024 ($0.02 Mil) but then increased from Dec. 2024 ($0.02 Mil) to Dec. 2025 ($0.02 Mil).

Gossamer Bio Common Stock Historical Data

* Premium members only.

The historical data trend for Gossamer Bio's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gossamer Bio Common Stock Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.02 0.02

Gossamer Bio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.05
GOSS
19GF Score
Gossamer Bio Inc GOSS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gossamer Bio Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.05 Mil mean?
Gossamer Bio (GOSS) has a Common Stock of $0.05 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gossamer Bio and its competitors.
Is Gossamer Bio's Common Stock too high?
Gossamer Bio's current Common Stock is $0.05 Mil. Overall, Gossamer Bio has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's Common Stock compare to PMVP and PLRX?
Gossamer Bio's Common Stock of $0.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Gossamer Bio and its competitors. Gossamer Bio's current Common Stock is $0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current Common Stock of $0.05 Mil. The current Common Stock is $0.05 Mil. Gossamer Bio's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current Common Stock is $0.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gossamer Bio Business Description

Other Exchanges 4GB:Germany
Address 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
19GF Score

Get the complete analysis for GOSS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price